Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(2-(oxazol-2-yl)-5-(4-(4-((propan-2-yl)oxy)benzenesulfonyl(piperazin-1-yl)phenoxy)acetic Acid
2. Bge 175
3. Bge-175
4. S-555739
1. 932372-01-5
2. Asapiprant [inn]
3. Bge-175
4. B2lw71crgl
5. S-555739
6. Bge175
7. 2-(5-(4-((4-isopropoxyphenyl)sulfonyl)piperazin-1-yl)-2-(oxazol-2-yl)phenoxy)acetic Acid
8. 2-(2-(oxazol-2-yl)-5-(4-(4-((propan-2-yl)oxy)benzenesulfonyl(piperazin-1-yl)phenoxy)acetic Acid
9. Acetic Acid, 2-(5-(4-((4-(1-methylethoxy)phenyl)sulfonyl)-1-piperazinyl)-2-(2-oxazolyl)phenoxy)-
10. Unii-b2lw71crgl
11. Bge175 [who-dd]
12. Schembl1106973
13. Chembl3545043
14. Gtpl11951
15. Bcp30346
16. Ex-a2993
17. Zb1516
18. Akos037515672
19. Cs-8174
20. Sb19848
21. Example Ii-74 [us8153793b2]
22. 2-[2-(1,3-oxazol-2-yl)-5-[4-(4-propan-2-yloxyphenyl)sulfonylpiperazin-1-yl]phenoxy]acetic Acid
23. Ac-36280
24. Bs-17884
25. Hy-16763
26. A16983
27. D80655
28. S-555739; Cs-2811
29. Q27274281
30. S-555739; S 555739; S555739
| Molecular Weight | 501.6 g/mol |
|---|---|
| Molecular Formula | C24H27N3O7S |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 501.15697138 g/mol |
| Monoisotopic Mass | 501.15697138 g/mol |
| Topological Polar Surface Area | 131 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 789 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
60
PharmaCompass offers a list of Asapiprant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Asapiprant manufacturer or Asapiprant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Asapiprant manufacturer or Asapiprant supplier.
PharmaCompass also assists you with knowing the Asapiprant API Price utilized in the formulation of products. Asapiprant API Price is not always fixed or binding as the Asapiprant Price is obtained through a variety of data sources. The Asapiprant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Asapiprant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Asapiprant, including repackagers and relabelers. The FDA regulates Asapiprant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Asapiprant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Asapiprant supplier is an individual or a company that provides Asapiprant active pharmaceutical ingredient (API) or Asapiprant finished formulations upon request. The Asapiprant suppliers may include Asapiprant API manufacturers, exporters, distributors and traders.
Asapiprant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Asapiprant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Asapiprant GMP manufacturer or Asapiprant GMP API supplier for your needs.
A Asapiprant CoA (Certificate of Analysis) is a formal document that attests to Asapiprant's compliance with Asapiprant specifications and serves as a tool for batch-level quality control.
Asapiprant CoA mostly includes findings from lab analyses of a specific batch. For each Asapiprant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Asapiprant may be tested according to a variety of international standards, such as European Pharmacopoeia (Asapiprant EP), Asapiprant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Asapiprant USP).
